Oral alkali therapy ( NaHCO3 ) to maintain serum bicarbonate levels between 23 and 29 mEq/L (23-29 mmol/L) reduces the risk of progression of chronic kidney disease.
If you want to change selection, open document below and click on "Move attachment"
pdf
owner:
ELBOMBARDO - (no access) - MKSAP_17.pdf, p3603
Summary
| status | not read | | reprioritisations | |
|---|
| last reprioritisation on | | | suggested re-reading day | |
|---|
| started reading on | | | finished reading on | |
|---|
Details